Testing effectiveness (Phase 2)Study completedNCT06671938
What this trial is testing
Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy
Who this might be right for
Parkinson DiseaseMultiple System Atrophy
BioArctic AB 38